The very mention of the name Neurontin must cause grimaces in the legal department at Pfizer.

One week after the company was hit with a $141 million RICO verdict for falsely marketing the epilepsy drug to Kaiser for off-label uses, Pfizer agreed to settle a products liability case blaming Neurontin for contributing to a user’s suicide. Though the amount of the payment is confidential, the settlement marks the first time Pfizer has agreed to pay out on a Neurontin suicide claim.